| 000 | 01735 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514192227.0 | ||
| 264 | 0 | _c20040727 | |
| 008 | 200407s 0 0 eng d | ||
| 022 | _a0007-1161 | ||
| 024 | 7 |
_a10.1136/bjo.2003.032979 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSharpe, E D | |
| 245 | 0 | 0 |
_aBrimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension. _h[electronic resource] |
| 260 |
_bThe British journal of ophthalmology _cJul 2004 |
||
| 300 |
_a953-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBrimonidine Tartrate |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlaucoma, Open-Angle _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntraocular Pressure _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOcular Hypertension _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aQuinoxalines _xadministration & dosage |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 |
_aThiophenes _xadministration & dosage |
| 700 | 1 | _aDay, D G | |
| 700 | 1 | _aBeischel, C J | |
| 700 | 1 | _aRhodes, J S | |
| 700 | 1 | _aStewart, J A | |
| 700 | 1 | _aStewart, W C | |
| 773 | 0 |
_tThe British journal of ophthalmology _gvol. 88 _gno. 7 _gp. 953-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bjo.2003.032979 _zAvailable from publisher's website |
| 999 |
_c14910882 _d14910882 |
||